Latest posts from Pharma Blogs
PharmaGossip » No go IPO
[Link]
THE PHARMA LAW BLOG » 4th of July Firworks.
Enjoy!By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [Link]
PharmaGossip » Are you going to the party?
.
[Link]PharmaGossip » Insider hears.....
Pfizer is working on a counter offer that will be 20% higher than the price offered by Japan's Daiichi Sankyo to buy a majority stake in Indian drugmaker Ranbaxy. [Link]
PharmaGossip » Worth a look
In the Pipeline » Happy Fourth of July
This, at least, I have observed in forty-five years: that there are men who search for it [truth], whatever it is, wherever it may lie, patiently, honestly, with due humility, and ...
[Link]Pharmalot » Alabama To Pharma: You Have 30 Days To Settle
The state is offering 69 drugmakers sued over alleged Medicaid price fixing 30 days to reach a settlement before taking further legal action, Reuters reports. In other words, pay up or ...
[Link]Pharmalot » Alabama To Pharma: You Have 30 Days To Settle
The state is offering 69 drugmakers sued over alleged Medicaid price fixing 30 days to reach a settlement before taking further legal action, Reuters reports. In other words, pay up or ...
[Link]Pharmalot » Judge Urges Lilly To Settle Zyprexa Lawsuits
US District Court Judge Jack Weinstein says the drugmaker faces a trial unless a settlement is reached in the long-running litigation in his New York court, which was filed by insurers, ...
[Link]Pharmalot » Judge Urges Lilly To Settle Zyprexa Lawsuits
US District Court Judge Jack Weinstein says the drugmaker faces a trial unless a settlement is reached in the long-running litigation in his New York court, which was filed by insurers, ...
[Link]Pharmalot » Judge Urges Lilly To Settle Zyprexa Suit For Billions
US District Court Judge Jack Weinstein has decided the drugmaker should finally resolve the long-running and controverisal litigation in his New York court, which was filed by insurers, unions and others ...
[Link]Pharmalot » Judge Urges Lilly To Settle Zyprexa Suit For Billions
US District Court Judge Jack Weinstein has decided the drugmaker should finally resolve the long-running and controverisal litigation in his New York court, which was filed by insurers, unions and others ...
[Link]Eye on FDA » Independence Day
It is July 4th weekend. Today will mean laying in the hammock with a good book and barbeque, weather permitting.
Have a good weekend everyone.
... [Link]PharmaGossip » Independence Day
[Link]
PharmaGossip » Print and post
WSJ.com: Health Blog » Independence Day
In observance of Independence Day, the Health Blog will not publish today.
Photo by Bob Jagendorf via Flickr
[Link]THE PHARMA LAW BLOG » Ever seen this sign in your doctor's office?
Then, perhaps you should print out and give him a copy?
From Pharmedout.org.By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement ... [Link]
THE PHARMA LAW BLOG » Department of Justice drowning in pharma whistleblower cases.
More than 900 cases alleging that government contractors and drugmakers have defrauded taxpayers out of billions of dollars are languishing in a backlog that has built up over the past ... [Link]
The IN VIVO Blog » DOTW: Fireworks
The long holiday weekend is upon us--a time for picnics, parades, and pyrotechnics. But before the industry's diehards decamped to beaches and backyards for obligatory BBQs and beer, a few ... [Link]
WSJ.com: Health Blog » Strong Medicine: Doctors Who Signed the Declaration of Independence
Who knows better than a doctor — witness to birth, sickness and death — that all men are created ...
[Link]The IN VIVO Blog » The Avandia Effect
Type 2 diabetes just entered the new era of drug development.
FDA’s Endocrine & Metabolic Drugs Advisory Committee’s recommended (by a 14-2 vote) that cardiovascular safety become a standard requirement for ... [Link]
PharmaGossip » Big Pharma - no angels in Montgomery contd.
The IN VIVO Blog » Pfizer/RaQualia: The Cost of Layoffs vs. Spin-Offs
As we hinted a few months ago, Pfizer finally managed to spin off some of its Nagoya, Japan research site into a venture-backed start-up, called RaQualia Pharma Inc. Negotiations ... [Link]
The IN VIVO Blog » Venture Wrap: No IPOs? Luxury!
You'll pardon us if we don't run shrieking down the streets after the National Venture Capital Association issued its recent mayday about the state of venture capital-backed IPOs.
Yes, the fact ... [Link]
WSJ.com: Health Blog » Hospital Company Sued for Billing Patients When Insurance Doesn’t Pay
Say you wind up in the hospital. The hospital bills your insurance, but the insurance company thinks the price is inflated and only pays part of what’s billed. So the hospital ...
[Link]Pharmalot » The Road To Hell Is Paved With Biological Plausibility
An FDA panel met for two days this week and voted 14 to 2 that diabetes drugs should be subject to additional testing to determine cardiovascular risk, a move that will ...
[Link]Pharmalot » No Chair Throwing Allowed At FDA Panel Meetings
Most days, an FDA advisory committee meeting would not be mistaken for an episode of one of those talk shows where the guests - and maybe even the host or audience ...
[Link]Pharmalot » The Road To Hell Is Paved With Biological Plausibility
An FDA panel met for two days this week and voted 14 to 2 that diabetes drugs should be subject to additional testing to determine cardiovascular risk, a move that will ...
[Link]Pharmalot » No Chair Throwing Allowed At FDA Panel Meetings
Most days, an FDA advisory committee meeting would not be mistaken for an episode of one of those talk shows where the guests - and maybe even the host or audience ...
[Link]Eye on FDA » FDA Posts New Education Vids on Safety Alerts
The FDA posted two new vids to its YouTube account. Much more than in the past, these are very timely, having only been issued this week and the vids are up. ...
[Link]WSJ.com: Health Blog » Elizabeth Edwards & a $40 Million Push for Health Coverage
A new group called Health Care for America Now is set to pour $40 million into a campaign-related push for universal health insurance.
The group ...
[Link]Pharmalot » Should Doctors Worry About Preemption?
Not surprisingly, the editors of The New England Journal of Medicine say ‘yes.’ Preemption, you may recall, is the notion that FDA approval supercedes state law claims challenging safety, efficacy, or ...
[Link]Pharmalot » Should Doctors Worry About Preemption?
Not surprisingly, the editors of The New England Journal of Medicine say ‘yes.’ Preemption, you may recall, is the notion that FDA approval supercedes state law claims challenging safety, efficacy, or ...
[Link]In the Pipeline » I Can Has Ugly Molecules?
A colleague and I were talking the other day about some of the molecules that turn up when you dig through a company's internal database. This was a favorite sport of ...
[Link]WSJ.com: Health Blog » In Germany, Assisted Suicide Rather Than a Nursing Home
Photo: Associated Press
A 79-year-old German woman killed herself last weekend because she didn’t want to move into a nursing home. Now ...
[Link]Pharmalot » Washington DC Sales Reps Must Follow These Rules
Earlier this year, the city became the first in the country to license sales reps, whose licenses can be revoked if their activities are deemed fraudulent. The bill was passed in ...
[Link]Pharmalot » So Many Whistleblowers, So Little Time
More than 900 cases alleging that government contractors and drugmakers have defrauded taxpayers out of billions of dollars are languishing in a backlog that has built up over the past decade ...
[Link]Pharmalot » Was The FDA Too Hasty In Approving Drugs?
A Harvard University professor defended research suggesting the FDA was too hasty in approving drug, which the agency has criticized as mistaken, The Wall Street Journal writes. The professor, Daniel Carpenter, ...
[Link]Pharmalot » A ‘No Trespassing’ Sign Aimed At Drug Reps
Doc, are you tired of being harangued with free pizza? Worried that slamming the door in a rep’s face is undignified? Well, if a more subtle approach is preferred, this ...
[Link]Pharmalot » FDA Offices Sign Deal On Regulatory Authority
The agreement between the Office of New Drugs and the Office of Surveillance & Epidemiology spells out which unit will take the lead on specific safety issues. And for drugmakers, this ...
[Link]Pharmalot » Pharmalot… Pharmalittle… A Long Weekend
Good morning, everyone. This is likely to be a short day, because here in the US, the Fourth of July holiday weekend is quickly approaching. For many, this pause in the ...
[Link]WSJ.com: Health Blog » FDA Panel: Test Diabetes Drugs For Heart Safety
A diabetes drug may lower blood sugar but still pose risks for the heart. So a panel of FDA advisers voted 14-2 yesterday that the FDA should require drug makers to ...
[Link]Pharmalot » Washington DC Sales Reps Must Follow These Rules
Earlier this year, the city became the first in the country to license sales reps, whose licenses can be revoked if their activities are deemed fraudulent. The bill was passed in ...
[Link]WSJ.com: Health Blog » Inside the Belly of Competitive Eating
The world’s greatest eaters are about to converge on Brooklyn for the annual Fourth of July hot-dog eating contest. As you’ll no doubt recall, Joey Chestnut ...
[Link]Pharmalot » So Many Whistleblowers, So Little Time
More than 900 cases alleging that government contractors and drugmakers have defrauded taxpayers out of billions of dollars are languishing in a backlog that has built up over the past decade ...
[Link]Pharmalot » A ‘No Trespassing’ Sign Aimed At Drug Reps
Doc, are you tired of being harangued with free pizza? Worried that slamming the door in a rep’s face is undignified? Well, if a more subtle approach is preferred, this ...
[Link]Pharmalot » Was The FDA Too Hasty In Approving Drugs?
A Harvard University professor defended research suggesting the FDA was too hasty in approving drug, which the agency has criticized as mistaken, The Wall Street Journal writes. The professor, Daniel Carpenter, ...
[Link]Pharmalot » FDA Offices Sign Deal On Regulatory Authority
The agreement between the Office of New Drugs and the Office of Surveillance & Epidemiology spells out which unit will take the lead on specific safety issues. And for drugmakers, this ...
[Link]Pharmalot » Pharmalot… Pharmalittle… A Long Weekend
Good morning, everyone. This is likely to be a short day, because here in the US, the Fourth of July holiday weekend is quickly approaching. For many, this pause in the ...
[Link]PharmaGossip » Deep breath
